Thomas Benzing Selected Research

Inflammation (Inflammations)

1/2022	Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury.
1/2019	Successful use of TNFα blockade in a severe case of idiopathic non-granulomatous ulcerative jejunoileitis associated with thrombotic thrombocytopenic purpura.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Benzing Research Topics

Disease

20	Proteinuria 07/2020 - 04/2003
10	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2010
9	Kidney Diseases (Kidney Disease) 01/2022 - 05/2005
8	Renal Insufficiency (Renal Failure) 01/2019 - 02/2005
6	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2022 - 05/2005
6	Reperfusion Injury 01/2022 - 01/2016
6	Pre-Eclampsia (Preeclampsia) 10/2020 - 08/2011
6	Neoplasms (Cancer) 01/2018 - 05/2007
6	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2016 - 10/2008
5	Cysts 12/2020 - 02/2005
5	Ciliopathies 01/2018 - 04/2008
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 12/2003
4	COVID-19 01/2022 - 07/2020
4	Hypoxia (Hypoxemia) 12/2019 - 05/2007
3	Albuminuria 01/2022 - 01/2017
3	Chronic Renal Insufficiency 07/2021 - 03/2016
3	Virus Diseases (Viral Diseases) 01/2021 - 01/2019
3	Fabry Disease (Fabry's Disease) 01/2019 - 01/2013
3	Ischemia 06/2018 - 07/2012
3	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2017 - 05/2007
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 03/2016 - 01/2006
2	Melanoma (Melanoma, Malignant) 10/2022 - 05/2016
2	Bartter Syndrome (Syndrome, Bartter) 10/2022 - 05/2016
2	Frailty 01/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 04/2017
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Infections 01/2021 - 01/2019
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 12/2020 - 07/2017
2	Sclerosis 01/2020 - 01/2018
2	Paraproteinemias (Monoclonal Gammopathy) 01/2019 - 06/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2017 - 07/2011
2	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2016 - 02/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 03/2015
2	Wilms Tumor (Wilm's Tumor) 09/2015 - 04/2015
2	Hydronephrosis 04/2015 - 06/2013
1	Hypertension (High Blood Pressure) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Multiple Myeloma 11/2020
1	Hematologic Neoplasms (Hematological Malignancy) 11/2020

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
9	NPHS2 proteinIBA 01/2022 - 07/2003
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
5	ProteomeIBA 01/2020 - 01/2018
5	MicroRNAs (MicroRNA)IBA 04/2016 - 11/2008
5	nephrinIBA 10/2008 - 04/2003
4	AlbuminsIBA 01/2022 - 07/2014
4	EnzymesIBA 01/2021 - 04/2015
4	CreatinineIBA 01/2018 - 07/2012
3	AntigensIBA 10/2022 - 05/2016
3	SaltsIBA 01/2022 - 05/2016
3	Rituximab (Mabthera)FDA Link 01/2021 - 01/2012
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2020 - 11/2009
3	Insulin (Novolin)FDA Link 03/2016 - 12/2009
3	Transcription Factors (Transcription Factor)IBA 09/2015 - 05/2007
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2017
2	Immunoglobulin M (IgM)IBA 01/2021 - 01/2016
2	Biological ProductsIBA 01/2021 - 12/2009
2	Immunoglobulin G (IgG)IBA 01/2021 - 06/2013
2	AntibodiesIBA 01/2021 - 01/2016
2	Contrast MediaIBA 01/2020 - 06/2018
2	CalciumIBA 01/2020 - 10/2016
2	Complement System Proteins (Complement)IBA 01/2019 - 01/2019
2	thiamine triphosphorate (TTP)IBA 01/2019 - 01/2012
2	AutoantibodiesIBA 01/2019 - 01/2016
2	alpha-Galactosidase (Beano)IBA 01/2019 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 06/2018 - 07/2012
2	Pharmaceutical PreparationsIBA 01/2018 - 11/2009
2	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 11/2012
2	Dextran SulfateIBA 03/2016 - 08/2011
1	IsotopesIBA 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Tricarboxylic AcidsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2022
1	EicosanoidsIBA 01/2022
1	Y-Box-Binding Protein 1IBA 01/2022
1	SulfurIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	anandamide (arachidonylethanolamide)IBA 05/2021
1	EndocannabinoidsIBA 05/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Ribavirin (Virazole)FDA LinkGeneric 01/2021
1	ChromatinIBA 11/2020
1	Monoclonal AntibodiesIBA 11/2020

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2010
5	Kidney Transplantation 07/2021 - 01/2011
4	Caloric Restriction 01/2022 - 01/2016
3	Blood Component Removal (Apheresis) 10/2020 - 08/2011
3	Plasma Exchange 01/2019 - 01/2011
2	Diet Therapy (Therapy, Diet) 01/2022 - 01/2020
2	Renal Dialysis (Hemodialysis) 07/2020 - 01/2018
1	Ketogenic Diet 01/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Organ Transplantation 07/2021
1	Drug Tapering 01/2021